all AI news
Alex Zhavoronkov to attend the PEGS Boston Summit from May 15-19
AI – AI-TechPark ai-techpark.com
Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that Alex Zhavoronkov, PhD, founder and CEO of the Company, will attend the PEGS Boston Summit from May 15-19. He will deliver a keynote presentation on “The State of the Science in Disease Modeling Across Diverse Indications” on May 15 at...
The post Alex Zhavoronkov to attend the PEGS Boston Summit from May 15-19 first appeared on AI-TechPark.
ai alex artificial artificial intelligence ceo discovery disease diverse drug discovery founder generative generative artificial intelligence insilico medicine intelligence keynote medicine modeling phd presentation science state summit